Table 5.
ANOVA Testing for Differences in Lymphoid Aggregate Numbers among Patients Divided According to Various Clinical Parameters
| |
Lymphoid Aggregate Density |
||
|---|---|---|---|
| Effect | F-value | DF (model, residual) | P-value |
| Neck | |||
| LM stage (de Serres)4 | 3.23 | 4,17 | 0.039* |
| Age at surgery | 2.39 | 1,20 | 0.137 |
| Previous sclerotherapy | 2.74 | 1,20 | 0.113 |
| Previous steroids | 0.01 | 1,20 | 0.928 |
| Lymphocytopenia | 2.37 | 1,20 | 0.139 |
| Recurrence | 0.00 | 1,20 | 0.9599 |
| Spontaneous regression | 0.17 | 1,20 | 0.6808 |
| Oral Cavity | |||
| LM stage (de Serres)4 | 0.74 | 3,11 | 0.551 |
| Age at surgery | 0.24 | 1,12 | 0.63 |
| Previous sclerotherapy | 0.01 | 1,12 | 0.906 |
| Previous steroids | 0.03 | 1,12 | 0.868 |
| Lymphocytopenia | 0.00 | 1,12 | 0.953 |
| Recurrence | 0.67 | 1,12 | 0.4295 |
| Persistent macroglossia/oral bleeding | 0.01 | 1,12 | 0.9395 |
*
p < 0.05.